American Medical Systems® (AMS) (Nasdaq: AMMD), a leading provider of world-class devices and therapies for both male and female pelvic health, today announced the 510(k) clearance of its revolutionary MoXy™ Liquid Cooled Fiber.
Designed to be used with the recently launched GreenLight XPS™ (Xcelerated Performance System), the MoXy liquid-cooled fiber provides fast and efficient tissue vaporization. MoXy's Active Cooling Cap™ technology utilizes 360-degree saline flow to maintain the temperature of the fiber tip for dramatically increased fiber longevity. The GreenLight XPS 180-watt laser combined with the MoXy fiber delivers 50 percent more power than the GreenLight HPS® (High Performance System) 120-watt system and a 50 percent increase in the laser beam area resulting in a faster and wider area of tissue vaporization. The new system maintains the same safety profile as the proven GreenLight HPS and PV systems, even with the increase in power and beam area.
"The MoXy fiber gives physicians the ability to utilize the GreenLight XPS system to its full potential for the treatment of enlarged prostate," said Joe Martin, senior vice president and general manager of BPH Therapies at AMS. "Vaporization efficiency is significantly improved to enable the removal of twice the tissue—as compared to our GreenLight HPS system— to effectively cut treatment time in half."
"GreenLight™ laser technology has significantly improved since the global introduction of the original 80-watt PV system in 2002," stated Dr. Reza Malek, who invented the procedure commonly known as Photoselective Vaporization of the Prostate (PVP) utilizing a prototype 60-watt system at the Mayo Clinic in 1997. "The 180-watt XPS system with the revolutionary MoXy fiber allows us to treat BPH faster and more safely than ever before, which is very exciting not only for us as clinicians, but also for our patients."
GreenLight XPS with the MoXy fiber is the latest in AMS' world-class portfolio of innovative, technologically advanced solutions to treat a variety of pelvic health conditions. Through its commitment to innovation and continuous improvement, AMS has become the recognized technology leader in both the men's and women's pelvic health markets. For more information about GreenLight XPS and MoXy, visit www.AMSGreenLight.com.
High levels of microplastics found in prostate tumors, possibly linked to take-out food